OBJECTIVE: Rheumatoid arthritis (RA) is a chronic inflammatory disease associated with premature atherosclerosis, vascular stiffening, and heart failure. This study was undertaken to investigate whether RA is associated with underlying structural and functional abnormalities of the left ventricle (LV). METHODS: Eighty-nine RA patients without clinical cardiovascular disease and 89 healthy matched controls underwent echocardiography, carotid ultrasonography, and radial tonometry to measure arterial stiffness. RA patients and controls were similar in body size, hypertension and diabetes status, and cholesterol level. RESULTS: LV diastolic diameter (4.92 cm versus 4.64 cm; P<0.001), mass (136.9 gm versus 121.7 gm; P=0.004 or 36.5 versus 32.9 gm/m2.7; P=0.01), ejection fraction (71% versus 67%; P<0.001), and prevalence of LV hypertrophy (18% versus 6.7%; P=0.023) were all higher among RA patients versus controls. In multivariate analysis, presence of RA was an independent correlate of LV mass (P=0.004). Furthermore, RA was independently associated with presence of LV hypertrophy (odds ratio 4.14 [95% confidence interval 1.24, 13.80], P=0.021). Among RA patients, age at diagnosis and disease duration were independently related to LV mass. RA patients with LV hypertrophy were older and had higher systolic pressure, damage index scores, C-reactive protein levels, homocysteine levels, and arterial stiffness compared with those without LV hypertrophy. CONCLUSION: The present results demonstrate that RA is associated with increased LV mass. Disease duration is independently related to increased LV mass, suggesting a pathophysiologic link between chronic inflammation and LV hypertrophy. In contrast, LV systolic function is preserved in RA patients, indicating that systolic dysfunction is not an intrinsic feature of RA.
OBJECTIVE:Rheumatoid arthritis (RA) is a chronic inflammatory disease associated with premature atherosclerosis, vascular stiffening, and heart failure. This study was undertaken to investigate whether RA is associated with underlying structural and functional abnormalities of the left ventricle (LV). METHODS: Eighty-nine RApatients without clinical cardiovascular disease and 89 healthy matched controls underwent echocardiography, carotid ultrasonography, and radial tonometry to measure arterial stiffness. RApatients and controls were similar in body size, hypertension and diabetes status, and cholesterol level. RESULTS: LV diastolic diameter (4.92 cm versus 4.64 cm; P<0.001), mass (136.9 gm versus 121.7 gm; P=0.004 or 36.5 versus 32.9 gm/m2.7; P=0.01), ejection fraction (71% versus 67%; P<0.001), and prevalence of LV hypertrophy (18% versus 6.7%; P=0.023) were all higher among RApatients versus controls. In multivariate analysis, presence of RA was an independent correlate of LV mass (P=0.004). Furthermore, RA was independently associated with presence of LV hypertrophy (odds ratio 4.14 [95% confidence interval 1.24, 13.80], P=0.021). Among RApatients, age at diagnosis and disease duration were independently related to LV mass. RApatients with LV hypertrophy were older and had higher systolic pressure, damage index scores, C-reactive protein levels, homocysteine levels, and arterial stiffness compared with those without LV hypertrophy. CONCLUSION: The present results demonstrate that RA is associated with increased LV mass. Disease duration is independently related to increased LV mass, suggesting a pathophysiologic link between chronic inflammation and LV hypertrophy. In contrast, LV systolic function is preserved in RApatients, indicating that systolic dysfunction is not an intrinsic feature of RA.
Authors: M Di Franco; M Paradiso; A Mammarella; V Paoletti; G Labbadia; L Coppotelli; E Taccari; A Musca Journal: Ann Rheum Dis Date: 2000-03 Impact factor: 19.103
Authors: P Verdecchia; G Carini; A Circo; E Dovellini; E Giovannini; M Lombardo; P Solinas; M Gorini; A P Maggioni Journal: J Am Coll Cardiol Date: 2001-12 Impact factor: 24.094
Authors: Charles G Helmick; David T Felson; Reva C Lawrence; Sherine Gabriel; Rosemarie Hirsch; C Kent Kwoh; Matthew H Liang; Hilal Maradit Kremers; Maureen D Mayes; Peter A Merkel; Stanley R Pillemer; John D Reveille; John H Stone Journal: Arthritis Rheum Date: 2008-01
Authors: William Bradham; Michelle J Ormseth; Comfort Elumogo; Srikanth Palanisamy; Chia-Ying Liu; Mark A Lawson; Jonathan H Soslow; Nadine Kawel-Boehm; David A Bluemke; C Michael Stein Journal: J Rheumatol Date: 2018-04-15 Impact factor: 4.666
Authors: John M Davis; Grace Lin; Jae K Oh; Cynthia S Crowson; Sara J Achenbach; Terry M Therneau; Eric L Matteson; Richard J Rodeheffer; Sherine E Gabriel Journal: Int J Cardiol Date: 2017-03-31 Impact factor: 4.164
Authors: Sonali P Desai; James L Januzzi; Ashvin N Pande; Eugene V Pomerantsev; Frederic S Resnic; Anne Fossel; Lori B Chibnik; Daniel H Solomon Journal: Semin Arthritis Rheum Date: 2010-06-11 Impact factor: 5.532
Authors: A Temiz; S Ozcan; F Gökmen; E Gazi; A Barutcu; A Bekler; B Altun; A Akbal; F Güneş; H Şen Journal: Z Rheumatol Date: 2014-12 Impact factor: 1.372
Authors: Elena Myasoedova; John M Davis; Cynthia S Crowson; Véronique L Roger; Barry L Karon; Daniel D Borgeson; Terry M Therneau; Eric L Matteson; Richard J Rodeheffer; Sherine E Gabriel Journal: Arthritis Rheum Date: 2013-07